ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,891,959 | -13.9% | 290,787 | -10.6% | 0.02% | -11.1% |
| Q2 2023 | $9,165,958 | -12.4% | 325,311 | +3.1% | 0.02% | -18.2% |
| Q1 2023 | $10,467,918 | +72472.9% | 315,650 | -13.5% | 0.02% | -18.5% |
| Q4 2022 | $14,424 | -99.6% | 364,982 | +298.6% | 0.03% | +170.0% |
| Q3 2022 | $3,756,000 | +113.8% | 91,574 | +109.5% | 0.01% | +150.0% |
| Q2 2022 | $1,757,000 | +241.8% | 43,705 | +198.0% | 0.00% | +300.0% |
| Q1 2022 | $514,000 | +26.0% | 14,667 | +25.9% | 0.00% | 0.0% |
| Q4 2021 | $408,000 | +9.4% | 11,650 | -2.6% | 0.00% | 0.0% |
| Q3 2021 | $373,000 | -29.5% | 11,959 | -21.9% | 0.00% | 0.0% |
| Q2 2021 | $529,000 | -2.8% | 15,311 | +4.5% | 0.00% | 0.0% |
| Q1 2021 | $544,000 | – | 14,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |